Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.
Makielski KM, Sarver AL, Henson MS, Stuebner KM, Borgatti A, Suksanpaisan L, Preusser C, Tabaran AF, Cornax I, O'Sullivan MG, Chehadeh A, Groschen D, Bergsrud K, Pracht S, Winter A, Mills LJ, Schwabenlander MD, Wolfe M, Farrar MA, Cutter GR, Koopmeiners JS, Russell SJ, Modiano JF, Naik S. Makielski KM, et al. Among authors: suksanpaisan l. Mol Ther Oncolytics. 2023 Oct 14;31:100736. doi: 10.1016/j.omto.2023.100736. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37965295 Free PMC article.
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK. Naik S, et al. Among authors: suksanpaisan l. Mol Cancer Ther. 2018 Jan;17(1):316-326. doi: 10.1158/1535-7163.MCT-17-0432. Epub 2017 Nov 20. Mol Cancer Ther. 2018. PMID: 29158470 Free PMC article.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Suksanpaisan L, Xu R, Tesfay MZ, Bomidi C, Hamm S, Vandergaast R, Jenks N, Steele MB, Ota-Setlik A, Akhtar H, Luckay A, Nowak R, Peng KW, Eldridge JH, Clarke DK, Russell SJ, Diaz RM. Suksanpaisan L, et al. Mol Ther Oncolytics. 2018 Jul 5;10:1-13. doi: 10.1016/j.omto.2018.05.001. eCollection 2018 Sep 28. Mol Ther Oncolytics. 2018. PMID: 29998190 Free PMC article.
Enhancing cytokine-induced killer cell therapy of multiple myeloma.
Liu C, Suksanpaisan L, Chen YW, Russell SJ, Peng KW. Liu C, et al. Among authors: suksanpaisan l. Exp Hematol. 2013 Jun;41(6):508-17. doi: 10.1016/j.exphem.2013.01.010. Epub 2013 Feb 8. Exp Hematol. 2013. PMID: 23403007 Free PMC article.
Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors.
Escobar-Zarate D, Liu YP, Suksanpaisan L, Russell SJ, Peng KW. Escobar-Zarate D, et al. Among authors: suksanpaisan l. Cancer Gene Ther. 2013 Oct;20(10):582-9. doi: 10.1038/cgt.2013.55. Epub 2013 Sep 13. Cancer Gene Ther. 2013. PMID: 24030211 Free PMC article.
35 results